0001209191-19-021036.txt : 20190322 0001209191-19-021036.hdr.sgml : 20190322 20190322171628 ACCESSION NUMBER: 0001209191-19-021036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190322 FILED AS OF DATE: 20190322 DATE AS OF CHANGE: 20190322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jones James CENTRAL INDEX KEY: 0001490829 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 19700676 MAIL ADDRESS: STREET 1: 2525 WEST END AVE., SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-22 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001490829 Jones James 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203 1 0 0 0 Common Stock 2019-03-22 4 A 0 1000 5.98 A 12700 D Restricted stock award will vest 100% on March 18, 2020. James Jones by /s/ Michael Bonner as attorney-in-fact 2019-03-22